• 253 Citations
  • 5 h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Amy Barnett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 253 Citations
  • 5 h-Index
  • 8 Article

Cirrhosis, gastrointestinal bleed, and cryptococcal peritonitis

Barnett, A. E. & Brust, K. B., Apr 2 2020, In : Baylor University Medical Center Proceedings. 33, 2, p. 195-198 4 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

    Mahadevan, D., Theiss, N., Morales, C., Stejskal, A. E., Cooke, L. S., Zhu, M., Kurtzman, D., Swart, R., Ong, E. & Qi, W., 2015, In : Oncotarget. 6, 4, p. 1954-1966 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 19 Scopus citations

    Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

    Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2210-2219 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 44 Scopus citations

    Phase i pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

    Mahadevan, D., Chiorean, E. G., Harris, W. B., Von Hoff, D. D., Stejskal-Barnett, A., Qi, W., Anthony, S. P., Younger, A. E., Rensvold, D. M., Cordova, F., Shelton, C. F., Becker, M. D., Garlich, J. R., Durden, D. L. & Ramanathan, R. K., Dec 1 2012, In : European Journal of Cancer. 48, 18, p. 3319-3327 9 p.

    Research output: Contribution to journalArticle

  • 75 Scopus citations

    SF1126, a Pan-PI3K inhibitor has potent pre-clinical activity in aggressive B-cell non-Hodgkin lymphomas by inducing cell cycle arrest and apoptosis

    Qi, W., Stejskal, A., Morales, C., Cooke, L. S., Garlich, J. R., Durden, D. & Mahadevan, D., Sep 17 2012, In : Journal of Cancer Science and Therapy. 4, 7, p. 207-213 7 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations